Re: Glaxo's Avandia Study in Jeopardy

In article <v44r53pius3a592krc254p1jhoblt71pef@xxxxxxx>,
Mâck©® <shootspammers@xxxxxxxxxxxxxxx> wrote:

On Wed, 30 May 2007 14:19:44 +0000 (UTC), Jonathan Grobe
<grobe@xxxxxxxxxx> wrote:

On 2007-05-30, Kurt <kurtwheeling1965@xxxxxxxxxxx> wrote:
http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070
528/reuters20070528health00000010reutershealthewEDIT.xml

or

http://tinyurl.com/2ygd7r

Glaxo's Avandia Study in Jeopardy: Official

(excerpt)

NEW YORK (Reuters) - Drug maker GlaxoSmithKline's medical director
said the company's study of the heart risk associated with its Avandia
diabetes treatment may be in jeopardy because patients have dropped
out following reports of the drug's risks, The New York Times reported
on Saturday.

I don't see why they don't report interim results; they have
a few years worth of data. (My suspicion is they are not because
the results are bad--that the data show a higer risk of heart
problems...).


isn't there an ethical question when those doing the research want to
try and find a way to keep people on the medication, when 1. those
people do not want the med because they don't trust it and 2. because
there is a question as to it's safety. People have the right to
refuse anything they do not want.

Of course, and no one is denying that.
.

Quantcast